Profile of:

Jorge Gratacós Masmitjà

Full name: Jorge Gratacós Masmitjà

Current country: Spain

Membership level: Full

Type of membership: Member

Number of publications: 15

Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2) (2021)

A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action (2021)

Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study (2021)

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52 (2020)

Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA (2020)

Social economic costs of ankylosing spondylitis in Spain (2020)

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis (2019)

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study (2019)

Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe (2019)

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis (2019)

Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study (2018)

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis (2018)

Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain (2018)

Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review (2017)

Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain (2017)